News Category:


UAH, HudsonAlpha team as part of national $31.5 million genetics effort

Dr. Eric Mendenhall says the new ENCODE research will enable scientists to further explore how cells work.

Research that will be done by The University of Alabama in Huntsville (UAH) and HudsonAlpha Institute for Biotechnology will provide a framework by which scientists can better understand ...

Small molecule inhibitor prevents or impedes tooth cavities in a preclinical model

Sadanandan Velu, left, and Hui Wu

University of Alabama at Birmingham researchers have created a small molecule that prevents or impedes tooth cavities in a preclinical model. The inhibitor blocks the function of a key virulence enzyme in an oral bacterium, a molecular sabotage that ...

HudsonAlpha and UAB awarded $10 million for newborn whole genome sequencing project

Huntsville, Ala. — HudsonAlpha Institute for Biotechnology, a nonprofit genomics and genetics research institute in Huntsville, Ala., in collaboration with the University of Alabama at Birmingham (UAB) School of Medicine and the University of Mississippi Medical Center, has been awarded a four-year, $10 million grant from the ...

UAH acquires DXA system for joint, bone and tissue research

While training to become a professional mountain bike racer, researcher Dr. Shannon Mathis discovered cyclists spend numerous hours exercising each week — yet most have low bone density. Since then, The University of Alabama in Huntsville (UAH) kinesiology professor has been consumed with learning more about bone ...
news categories: ,

A novel anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

Ichiro Nakano, M.D., Ph.D.

Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells — glioma stem cells — is responsible for glioblastoma’s tumorigenesis, treatment resistance and subsequent tumor recurrence. A collaborative ...
news categories: , ,

Micron-sized hydrogel cubes show highly efficient delivery of a potent anti-cancer drug

Many potent anti-cancer drugs have major drawbacks — they fail to mix with water, which means they will have a limited solubility in blood, and they lack selectivity to cancer cells. Researchers at the University of Alabama at Birmingham and Texas Tech University Health Sciences ...

Auburn University home to new pharmaceutical building

U.S. News and World Report ranks The Harrison School of Pharmacy at Auburn University as one of the top 25 pharmacy schools in the country, and their new pharmaceutical building matches their ranking. The 37,000 square foot building took 16 months and $16.6 million to complete, but it is expected ...

HealthSouth partners with Auburn University School of Nursing

HealthSouth Corporation of Birmingham recently invested $325,000 in Auburn University's School of Nursing, solidifying the partnership between the healthcare provider and the university's nursing program. HealthSouth's gift supports the School of Nursing's effort to raise $5.6 million in private funding to match university funds for Auburn's first facility specifically built and designed for nursing education. It ...
news categories: ,

Shadow program gives aspiring undergraduates a sneak-peek of UAH’s research opportunities

Students from area high schools and community colleges spent an afternoon shadowing undergraduate members of UAH’s Summer Community of Scholars.

Earlier this month, a dozen students from area high schools and community colleges were invited to spend an afternoon at The University of Alabama in ...
news categories: ,

2015 BioAlabama Symposium & Annual Meeting

Announcing the 2015 BioAlabama Science Symposium and Annual Meeting on May 13 at the DoubleTree Hotel in Birmingham, AL!

news categories: ,